Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)
| Image |  |
|---|---|
| Description | article by J. R. Infante et al published 20 June 2011 in Journal of Clinical Oncology |
| Author/s | |
| Publication date | June 20, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |